18:24:35 EST Thu 03 Dec 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:IPHA - INNATE PHARMA SPON ADS EACH REP 1 ORD SH - Website unknown - click to update18:24:35 EST
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
IPHA - Q0.24.59·8.000.55.32+0.163.15.128315.53  5.60  5.328.24  3.3016:00:0008:3015 min RT 2¢

Recent Trades - Last 10 of 31
Time ETExPriceChangeVolume
16:00:00Q5.310.1575
15:58:54Q5.320.16100
15:58:01Q5.5850.425100
15:58:01Q5.570.41100
15:58:01Q5.580.42121
13:59:32Q5.450.2940
13:59:03Q5.34080.18085
12:24:58Q5.330.17500
12:24:58Q5.440.281
12:24:58Q5.330.1729

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolTypeHeadline
2020-12-03 08:30U:IPHANews ReleaseInnate Pharma to Present Additional Efficacy Data for Monalizumab in Combination With Cetuximab in Head and Neck Cancer at the ESMO Immuno-Oncology Virtual Congress
2020-12-03 04:45U:IPHANews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Innate Pharma S.A. - IPHA
2020-12-02 01:00U:IPHANews ReleaseInnate Pharma 2021 Financial Calendar
2020-12-02 00:30U:IPHANews ReleaseROSEN, A LEADING LAW FIRM, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in Securities Class Action; Encourages Investors with Losses Exceeding $100K to Contact the Firm - IPHA
2020-11-21 13:06U:IPHANews ReleaseLEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
2020-11-17 01:00U:IPHANews ReleaseInnate Pharma Reports Third Quarter 2020 Financial Results and Business Update
2020-11-14 14:00U:IPHANews ReleaseROSEN, A TOP RANKED LAW FIRM, Reminds Innate Pharma S.A. Investors of Important December 22 Deadline in First Filed Securities Class Action Commenced by the Firm; Encourages Investors with Losses Exceeding $100K to Contact Firm - IPHA
2020-11-13 01:00U:IPHANews ReleaseInnate Pharma Receives Prime Designation From the European Medicines Agency for Lacutamab in S ©zary Syndrome
2020-11-12 01:00U:IPHANews ReleaseInnate Pharma to Participate in upcoming investor conferences